Trade Names:Didrex- Tablets 25 mg- Tablets 50 mg
Stimulates satiety center in brain, causing appetite suppression.
Short-term (few weeks) adjunct to diet plan to reduce weight.
Hypersensitivity to sympathomimetic amines; pregnancy; advanced arteriosclerosis; symptomatic cardiovascular disease; moderate to severe hypertension; hyperthyroidism; glaucoma; agitated states; history of drug abuse; during or within 14 days of MAOI use; coadministration with other CNS stimulants.
PO 25 to 50 mg 1 to 3 times daily.
Store at room temperature in tightly closed, light-resistant container.
May decrease hypotensive effect.MAOIs, (eg, furazolidone)
May cause hypertensive crisis and intracranial hemorrhage.SSRIs (eg, fluoxetine)
Sympathomimetic effects of benzphetamine may be increased; increased risk of “serotonin syndrome.”
None well documented.
Palpitations; tachycardia; arrhythmias; hypertension; hypotension; chest pain.
Hypersensitivity; dizziness; insomnia; euphoria; tremor; headache; restlessness; overstimulation; nervousness; anxiety; agitation.
Urticaria; rash; erythema; hair loss.
Mydriasis; blurred vision; unpleasant taste.
Dry mouth; nausea; diarrhea; constipation; stomach pain.
Dysuria; urinary frequency; impotence; menstrual disturbances.
Bone marrow depression; agranulocytosis; leukopenia.
Excessive sweating; flushing; myalgia; gynecomastia.
Category X .
Not recommended for children under 12 yr of age.
Some products contain tartrazine, which may cause allergic-type reactions in susceptible individuals.
High potential for dependence and abuse; tolerance may occur.
Restlessness, tremor, rapid respirations, tachypnea, dizziness, confusion, mood changes, panic states, dysrhythmias, palpitations, and hypertension or hypotension.
Copyright © 2009 Wolters Kluwer Health.